澳門旅遊業界:疫苗互認配合港澳「通關」 料未來日均旅客可達六萬
據《澳門日報》報道,就澳門行政長官賀一誠昨透露正商討與內地疫苗互認機制,起碼先與廣東相認,另外,待港零確診連續十四天,將盡快恢復兩地人員往來。澳門旅遊業者表示,限制措施鬆綁,有助刺激自由行及港客訪澳意慾,屆時客量有望恢復至日均5萬至6萬人次水平。
澳門旅遊業議會會長胡景光表示,廣東省佔自由行客比例一半或以上,只要疫苗互認機制推開,同時免核酸、恢復網簽等政策可同步落實,屆時自由行客市場可恢復疫前七八成,日均入境客量可達4萬至5萬。
另一方面,香港客源市場不容忽視,若可與香港恢復通關,保守估計可恢復一半客源,即日均約1萬港客,加上內地客,兩者合共有5-6萬客。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.